BIO Declaration on Global Access to COVID-19 Vaccines and Treatments and Role of IP

In a message distributed to Biotechnology Innovation Organization (BIO) members, Dr. Michelle McMurry-Heath, BIO President and CEO, released a declaration signed by the corporate and organizational leaders of 209 global biotechnology companies and 41 biotech associations, in which the signatories acknowledged their "social responsibility to work with other stakeholders -- healthcare providers, governments, multilateral organizations, and non-governmental donor organizations -- to ensure that...
By: McDonnell Boehnen Hulbert & Berghoff LLP

Array